ISCTM and ECNP | Posters & Presentations - Cambridge Cognition
We’re attending ISCTM 2025 and ECNP 38th Congress 2025 to share our latest research on CNS drug development, psychiatry, and cognitive neuroscience.| Cambridge Cognition
The post A Warm Welcome for Older Audiences at Hove Museum appeared first on Brighton & Hove Museums.| Brighton & Hove Museums
CTAD | Posters & Presentations Hilton San Diego Bayfront, 1 Park Boulevard – San Diego, CA 92101 | 1-4th December We’re excited to announce we are attending the 18th Clinical Trials on Alzheimer’s Disease (CTAD) This year’s Clinical Trials on Alzheimer’s Disease (CTAD) conference brings together global leaders advancing research and innovation in Alzheimer’s and […] The post CTAD | Posters & Presentations appeared first on Cambridge Cognition.| Cambridge Cognition
DIS | Posters & Presentations Pfizer Innovation Research (PfIRe Lab) 1 Portland St Cambridge, MA 02139 | 5th November 09:00am – 5:30pm PST We’re excited to announce that our team will be attending the 8th Annual Digital Implementation Summit This year’s Digital Implementation Summit brings together global leaders driving the transformation of clinical development from […] The post DIS | Posters & Presentations appeared first on Cambridge Cognition.| Cambridge Cognition
CTIS | Posters & Presentations Genentech, South San Francisco, CA, USA | 15th October 08:30am – 5:30pm PST We’re excited to announce that our team will be attending the 2nd Annual Clinical Trial Innovation Summit 2025 This years Clinical Trial Innovation Summit brings together global leaders driving the future of clinical research and we’re proud […] The post CTIS | Posters & Presentations appeared first on Cambridge Cognition.| Cambridge Cognition
We’re attending ISCTM 2025 and ECNP 38th Congress 2025 to share our latest research on CNS drug development, psychiatry, and cognitive neuroscience.| Cambridge Cognition
How Picture Description Tasks Can Help Track Cognitive Health Remotely Speech as a digital biomarker in clinical research Changes in how we speak—how quickly we talk, how often we pause, and the words we choose—can be early signs of cognitive decline. People with mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) often […]| Cambridge Cognition
Cognition in The Blood (Biomarker) How do digital cognitive assessments relate to the Blood Plasma p-Tau217 in patients with Mild Cognitive Impairment (MCI)? Our latest research explores an exciting dataset with the AI–Mind Project, who have given us the opportunity to test the associations of our cognitive assessments alongside classic paper-and-pencil tests to levels of […] The post Cognition in The Blood (Biomarker) appeared first on Cambridge Cognition.| Cambridge Cognition
In a new study, Nobel laureate David Baker and colleagues detail new methods for targeting undruggable "disordered" proteins.| STAT
Alzheimer’s disease and other forms of dementia profoundly impact millions of individuals and their families. Often diagnosed too late for effective intervention, these conditions highlight the critical need for early detection. Early screening trials for Alzheimer’s are emerging as a game-changing approach, offering hope for earlier intervention, innovative treatments, and a better quality of life. … Memory Loss and Alzheimer’s: How Early Screening Trials Could Change Lives Read More »| Princeton Medical Institute
Alzheimer’s and dementia are complex, progressive conditions that impact millions of individuals and their families around the world. In the pursuit of effective treatments, clinical trials play an essential role, driving advancements in care, expanding treatment options, and offering hope to those affected. Through rigorous testing and research, clinical trials not only pave the way … The Role of Clinical Trials in Advancing Alzheimer’s and Dementia Care Read More »| Princeton Medical Institute
